Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
Holding FOLD?
Track your performance easily
Amicus (FOLD) Ownership Overview
1.15% Insiders
33.46% Mutual Funds
38.57% Other Institutional Investors
16.63% ETFs
10.19% Public Companies and
Individual Investors
The ownership structure of Amicus (FOLD) stock is a mix of institutional, retail, and individual investors. Approximately 88.67% of the company’s stock is owned by Institutional Investors, 1.15% is owned by Insiders, and 10.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 07, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $98763 |
| Nov 04, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $85950 |
| Oct 04, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $79425 |
| Sep 05, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $87750 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $232001 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $10982105 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $10987584 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,057,456 | Institution | 9.39% | 272,718,472 | |
| 27,247,762 | Institution | 9.12% | 264,848,247 | |
| 25,046,990 | Institution | 8.38% | 243,456,743 | |
| 16,286,876 | Institution | 5.45% | 158,308,435 | |
| 13,651,186 | Institution | 4.57% | 132,689,528 | |
| 9,122,120 | Institution | 3.05% | 88,667,006 | |
| 6,272,921 | Institution | 2.10% | 60,972,792 | |
| 5,162,491 | Institution | 1.73% | 50,179,413 | |
| 4,803,663 | Institution | 1.61% | 46,691,604 | |
| 3,492,476 | Institution | 1.17% | 33,946,867 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,046,990 | Institution | 8.38% | 243,456,743 | |
| 16,286,876 | Institution | 5.45% | 158,308,435 | |
| 9,122,120 | Institution | 3.05% | 88,667,006 | |
| 6,272,921 | Institution | 2.10% | 60,972,792 | |
| 5,162,491 | Institution | 1.73% | 50,179,413 | |
| 3,492,476 | Institution | 1.17% | 33,946,867 | |
| 3,323,330 | Institution | 1.11% | 32,302,768 | |
| 3,277,766 | Institution | 1.10% | 31,859,886 | |
| 2,863,227 | Institution | 0.96% | 27,830,566 | |
| 2,849,507 | Institution | 0.95% | 27,697,208 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,324,423 | Institution | 3.12% | 106,484,911 | |
| 7,435,485 | Institution | 2.49% | 84,913,239 | |
| 8,053,823 | Institution | 2.70% | 78,283,160 | |
| 4,088,273 | Institution | 1.37% | 46,688,078 | |
| 3,964,944 | Institution | 1.33% | 45,279,660 | |
| 4,335,042 | Institution | 1.45% | 41,876,506 | |
| 2,636,873 | Institution | 0.88% | 25,630,406 | |
| 1,997,446 | Institution | 0.67% | 19,415,175 | |
| 1,337,325 | Institution | 0.45% | 15,272,252 | |
| 1,291,544 | Institution | 0.43% | 12,476,315 |
FAQ
Who Owns Amicus Therapeutics (FOLD)?
According to the latest TipRanks data, approximately 38.57% of the company's stock is held by institutional investors, 1.15% is held by insiders, and 10.19% is held by retail investors.
What percentage of Amicus Therapeutics (FOLD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.57% of Amicus Therapeutics (FOLD) stock is held by institutional investors.
What percentage of Amicus Therapeutics (FOLD) stock is held by retail investors?
According to the latest TipRanks data, approximately 10.19% of Amicus Therapeutics (FOLD) stock is held by retail investors.
Who owns the most shares of Amicus Therapeutics (FOLD)?
Joseph Edelman owns the most shares of Amicus Therapeutics (FOLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.